November 30, 2023
`
`
`
`
`
`
`
`
`
`ASHLEY GRAHAM
`Associate
`212-294-1727
` AGraham@winston.com
`
`
`Erica R. Sutter
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`esutter@fenwick.com
`
`Re:
`
`In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 3038, No. 22-cv-294-CFC
`(D. Del.) (consolidated)
`
`Dear Counsel:
`
`Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, “DRL”)
`hereby produce via FTP DRL’s production of documents bearing Bates numbers DRL_0158219-
`DRL_0158307. The documents can be accessed via the following link:
`
`• FTP Link:
`
`
`
`
`• FTP Password:
`
`Please note that these documents have been marked “Confidential” pursuant to the
`Protective Order Governing the Collection and Production of Documents and Electronically Stored
`Information entered by the Court on August 08, 2022 (the “Protective Order”) (Dkt. 51). To the
`extent that any privileged documents are inadvertently produced, DRL does not waive its right to
`retrieve them.
`
`
`Best regards,
`
`/s/ Ashley Graham
`Ashley Graham
`
`
`
`
`Cc: Counsel of record
`
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00001
`
`
`
`
`
`
`
`
`
`
`
`ASHLEY GRAHAM
`Associate
`212-294-1727
` AGraham@winston.com
`
`
`Erica R. Sutter
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`esutter@fenwick.com
`
`Re:
`
`In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 3038, No. 22-cv-294-CFC
`(D. Del.) (consolidated)
`
`Dear Counsel:
`
`Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, “DRL”)
`hereby produce via FTP DRL’s production of documents bearing Bates numbers DRL_0158219-
`DRL_0158307. The documents can be accessed via the following link:
`
`• FTP Link:
`
`
`
`
`• FTP Password:
`
`Please note that these documents have been marked “Confidential” pursuant to the
`Protective Order Governing the Collection and Production of Documents and Electronically Stored
`Information entered by the Court on August 08, 2022 (the “Protective Order”) (Dkt. 51). To the
`extent that any privileged documents are inadvertently produced, DRL does not waive its right to
`retrieve them.
`
`
`Best regards,
`
`/s/ Ashley Graham
`Ashley Graham
`
`
`
`
`Cc: Counsel of record
`
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00001
`
`
`
`From:
`Sent:
`To:
`
`Cc:
`Subject:
`
`Huang, Karen (Perkins Coie) <KHuang@perkinscoie.com>
`Friday, October 27, 2023 11:22 AM
`jblumenfeld@morrisnichols.com; began@morrisnichols.com; tmurray@morrisnichols.com;
`jfc@schraderlaw.com; Laura Moran; Robert Counihan; Jeff Oelke; Ryan Johnson; Erica Sutter; Olivia
`Wheeling; Silvia Medina; Vanessa Park-Thompson; Allie Cohen Dolloff; Ryan Haddad; Michael Yoon;
`Retley Locke
`Semaglutide-Ozempic@perkinscoie.com; stamoulis@swdelaw.com; weinblatt@swdelaw.com
`In re: Ozempic (Semaglutide) Patent Litigation (Nos. 22-MD-3038, 22-1040)
`
`** EXTERNAL EMAIL **
`Counsel,
`
`Documents numbered MPI-SM00046891 - MPI-SM00046930 and MPI-8MG-SM0008670 - MPI-8MG-SM0008712 will be
`produced by FTP at the following links:
`
`Password for the FTPs and productions will follow separately.
`
`Please note that these documents have been designated as “Confidential Information – Subject to Protective Order”
`pursuant to the Stipulated Protective Order. Please treat these documents accordingly.
`
`
`
`
`
`Regards,
`
`Karen Huang | Perkins Coie LLP
`SENIOR PARALEGAL
`1120 N.W. Couch Street Tenth Floor
`Portland, OR 97209-4128
`D. +1.503.727.2260
`F. +1.503.727.2222
`E. KHuang@perkinscoie.com
`
`NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the sender by reply email and
`immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
`
`1
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00002
`
`
`
`From:
`Sent:
`To:
`Cc:
`Subject:
`
`West, Christopher W. <christopher.west@katten.com>
`Tuesday, November 21, 2023 12:25 PM
`Erica Sutter; Laura Moran; farnan@rlf.com; Caras, Valerie A.; FW Sema
`Ferenc, Christopher B.; Sodikoff, Brian
`RE: Document production: In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 3038, C.A. No.
`22-cv-294-CFC (CONSOLIDATED) (D. Del.)
`
`** EXTERNAL EMAIL **
`Hi Erica,
`
`Sun is providing a production via secure FTP today, bearing the Bates Range: SUN-SEMA_0249229 - SUN-
`SEMA_0249453. Passwords to access the site and open this production will follow separately. The link to access the
`documents is:
`
`Login:
`
`
`
`
`
`If you have any issues downloading the documents, please contact us.
`
`Best regards,
`
`Chris
`
`Christopher W. West, Ph.D.
`Counsel
`Katten
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900 | Charlotte, NC 28202-4213
`direct +1.704.344.3098 mobile +1.707.315.8386
`christopher.west@katten.com | katten.com
`
`===========================================================
`CONFIDENTIALITY NOTICE:
`This electronic mail message and any attached files contain information intended for the
`exclusive
`use of the individual or entity to whom it is addressed and may contain information that
`is
`proprietary, privileged, confidential and/or exempt from disclosure under applicable law.
`If you
`are not the intended recipient, you are hereby notified that any viewing, copying,
`disclosure or
`distribution of this information may be subject to legal restriction or sanction. Please
`notify
`the sender, by electronic mail or telephone, of any unintended recipients and delete the
`original
`message without making any copies.
`===========================================================
`NOTIFICATION: Katten Muchin Rosenman LLP is an Illinois limited liability partnership
`that has
`
`1
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00003
`
`
`
`elected to be governed by the Illinois Uniform Partnership Act (1997).
`===========================================================
`
`
`2
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00004
`
`
`
`
`
`Patricia A. Skinner
`Direct Dial: (312) 836-4070
`E-Mail: pskinner@taftlaw.com
`
`
`
`
`
`
`
`October 5, 2023
`
`VIA ELECTRONIC MAIL & SECURE SEND
`
`
`
`Erica Sutter
`FENWICK & WEST LLP
`902 Broadway, Suite 14
`New York, New York 10010-6035
`(212) 430-2600
`
`
`
`Dear Ms. Sutter:
`
`Re: Novo Nordisk Inc., et al. v. Rio Biopharmaceuticals, Inc., et al. 22-cv-00294-
`CFC (D. Del.)
`
`Rio Biopharmaceuticals, Inc. has posted a production bearing Bates numbers RIO-SEM-
`00041658 through RIO-SEM-00048828 to a secure site for your download. Many of these
`documents are marked Highly Confidential Subject to Protective Order and should be treated
`accordingly. The login and password credentials for accessing the documents will be forwarded
`by separate email and the documents will only be available through October 13, 2023. If you
`have any questions or concerns regarding this production, please direct these to me at the above
`telephone number or email address.
`
`Sincerely,
`
`/s/ Patricia A. Skinner
`
`Patricia A. Skinner
`
` Stephen R. Auten
`Richard T. Ruzich
`Philip Y. Kouyoumdjian
`Jaimin Shah
`Kenneth L. Dorsney
`Attached Service List
`
`
`cc:
`
`
`
`
`
`
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00005
`
`
`
`
`
`
`
`
`FENWICK & WEST LLP
`902 Broadway, Suite 14
`New York, New York 10010-6035
`(212) 430-2600
`
`Jeffrey J. Oelke
`Ryan P. Johnson
`Robert E. Counihan
`Laura T. Moran
`Erica R. Sutter
`Olivia Wheeling
`Alexandra Cirra
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Service List
`
`
`
`joelke@fenwick.com
`ryan.johnson@fenwick.com
`rcounihan@fenwick.com
`laura.moran@fenwick.com
`esutter@fenwick.com
`owheeling@fenwick.com
`acirra@fenwick.com
`FW-Sema@fenwick.com
`
`Jack B. Blumenfeld (#1014)
`Brian Egan
`Travis Murray
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@morrisnichols.com
`began@morrisnichols.com
`tmurray@morrisnichols.com
`
`
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00006
`
`
`
`111 South Wacker Drive
`Suite 4100
`Chicago, IL 60606
`Telephone: 312-443-0700
`Fax: 312-443-0336
`www.lockelord.com
`
`
`Jacob C. Britz
`Direct Telephone: 312-443-0632
`Direct Fax: 312-896-6333
`jacob.britz@lockelord.com
`
`
`
`
`July 25, 2023
`
`BY EM AIL
`
`Ryan P. Johnson
`Fenwick and West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`
`Re:
`
`In Re: Ozempic (Semaglutide) Patent Litigation,
`MDL No. 22-3038-CFC (D. Del.)
`
`Dear Ryan:
`
`Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
`(collectively “Zydus”) hereby produce documents bearing production numbers
`ZYDSEM_0031808 - ZYDSEM_0035995. Please note that these documents are being
`produced as “Confidential Information – Subject to Protective Order.”
`
`The documents are available for download on a secure, password -protected website located at:
`
`URL:
`
`
`For security purposes, a separate e-mail will be sent to you containing the password required to
`access this production.
`
`Zydus reserves the right to recall any document that is later determined to have been
`inadvertently produced. The production of these documents should not be construed as an
`admission that any document in this production is relevant or admissible.
`
`If you have any questions, please do not hesitate to contact me.
`
`Best regards,
`
`
`
`LOCKE LORD LLP
`
`
`
`
`
`Jacob C. Britz
`
`Atlanta | Austin | Boston | Brussels | Chicago | Cincinnati | Dallas | Hartford | Houston | London | Los Angeles
`Miami | New Orleans | New Y ork | Newark | Providence | San Francisco | Stamford | Washington DC | West Palm Beach
`
`Novo Nordisk Exhibit 2020
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00007
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
